Section 7: Training
Training is required for all research personnel working with recombinant or synthetic nucleic acid molecules and biohazardous materials, agents and toxins. Completion of the courses is a requirement for the approval of new and continuing Biosafety and Recombinant protocols. All existing training materials and course content required by the IBC will be reviewed every two years by a subcommittee of IBC members, and any new training material or course content will be reviewed by a subcommittee of IBC members prior to release.
All IBC members will complete OH207 and CW512 and receive initial training regarding the IBC Policies. A handbook and other essential training can be found on the ORS webpage (http://www.utexas.edu/research/rsc/ibc/handbook.html).
The training program for all members consists of information provided at each IBC meeting. The objectives of providing ongoing training for IBC members is to increase their knowledge, understanding and awareness of current laws and regulations, new directives, best practice guidelines and institutional policies. It also provides a regular forum for the IBC to discuss concerns or questions brought forth by the faculty and research personnel. Information provided for these sessions will include questions and concerns brought to the attention of the IBC, official directives, relevant publications, conference announcements, seminar proceedings, and compliance issues. It will be the responsibility of the IBC Program Coordinator to document all training.
The BSO is a Certified Biosafety Professional (CBSP), a certification requiring continuing education in biosafety. The BSO, designated by the University as professional personnel, has the job requirement to maintain CBSP certification so training must be upheld by EHS.
General biosafety training (OH207) is mandatory for all Principal Investigators and research personnel. The NIH Guidelines (CW512) training is mandatory only for Principal Investigators and research personnel performing recombinant or synthetic nucleic acid molecules research that is non-exempt. Principal Investigators and research personnel who collect or work with human and non-human primate’s fluids, tissues or cells (including cell lines) are required to take Bloodborne Pathogen training (OH 218), renewed annually. It is the Principal Investigator’s responsibility to complete and ensure all research personnel has received the required training prior to protocol review by IBC. Documentation of successful completion of training is required in order to receive IBC approval. Information and links to IBC required training courses can found on the ORS website: http://www.utexas.edu/research/rsc/ibc/training.html